ADAM10 Gene Polymorphism and Its Relationship to Hepatocellular Carcinoma in Egyptian HCV Patients Receiving Direct-Acting Antiviral Therapies (DAAs)

OBJECTIVE: The aim of this study was to investigate the ADAM 10 rs.653765 SNP genetic polymorphism in the hepatocellular carcinoma occurrence (de novo and post DAAs). METHODS: This study was conducted on 360 participants divided to 4 groups. Group 1: 90 chronic adult patients infected with HCV recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghanem, Samar, El Gedawy, Gamalat, Yehia, Sania, Bedair, Hanan, Awad, Samah, Abdel-Razek, Wael, Elhelbawy, Mostafa, EL-Sabaawy, Dalia, Elfert, Ashraf Yousif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152868/
https://www.ncbi.nlm.nih.gov/pubmed/36708563
http://dx.doi.org/10.31557/APJCP.2023.24.1.149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152868/
https://www.ncbi.nlm.nih.gov/pubmed/36708563
http://dx.doi.org/10.31557/APJCP.2023.24.1.149

Ejemplares similares